$1.98-0.50%
2026-10-05 closeAcrivon Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$89M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy
Acrivon Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$89M.